• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CHILDREN WITH CYSTIC FIBROSIS HOSPITALISED WITH COVID-19: MULTICENTRE EXPERIENCE.

作者信息

Al Yazidi Laila S, Al Maskari Nawal, Al Reesi Mohammed

机构信息

Child Health Department, Sultan Qaboos University Hospital, Muscat, Oman.

Child Health Department, Royal Hospital, Muscat, Oman.

出版信息

J Paediatr Child Health. 2021 May;57(5):767-768. doi: 10.1111/jpc.15495. Epub 2021 Apr 15.

DOI:10.1111/jpc.15495
PMID:33856079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8250517/
Abstract
摘要

相似文献

1
CHILDREN WITH CYSTIC FIBROSIS HOSPITALISED WITH COVID-19: MULTICENTRE EXPERIENCE.因新冠病毒肺炎住院的囊性纤维化患儿：多中心经验
J Paediatr Child Health. 2021 May;57(5):767-768. doi: 10.1111/jpc.15495. Epub 2021 Apr 15.
2
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗预防囊性纤维化儿童呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD007743. doi: 10.1002/14651858.CD007743.pub3.
3
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗用于预防囊性纤维化患儿的呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2013 Jun 5(6):CD007743. doi: 10.1002/14651858.CD007743.pub4.
4
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗用于预防囊性纤维化患儿的呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2014 May 22(5):CD007743. doi: 10.1002/14651858.CD007743.pub5.
5
Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era.2019冠状病毒病（COVID-19）时代的呼吸道合胞病毒与帕利珠单抗预防
CMAJ. 2021 Apr 12;193(15):E523. doi: 10.1503/cmaj.78240.
6
Alternative Viewpoint: Efficacy and Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Children with Cystic Fibrosis - An Unsolved Question with More to Be Asked.另一种观点：呼吸道合胞病毒免疫预防对囊性纤维化儿童的疗效和有效性——一个有待进一步探讨的未解决问题。
Pharmacotherapy. 2017 Nov;37(11):e120-e121. doi: 10.1002/phar.2029. Epub 2017 Oct 26.
7
Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005-2016).囊性纤维化患者的呼吸道合胞病毒预防：帕利珠单抗数据加拿大注册研究（2005-2016 年）。
Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1345-1352. doi: 10.1007/s10096-018-3256-0. Epub 2018 May 4.
8
Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.对患有囊性纤维化的婴儿进行帕利珠单抗预防，并不会延迟首次分离出铜绿假单胞菌或金黄色葡萄球菌的时间。
Eur J Pediatr. 2017 Jul;176(7):891-897. doi: 10.1007/s00431-017-2926-8. Epub 2017 May 16.
9
Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis.帕利珠单抗对囊性纤维化患者预防呼吸道合胞病毒感染是否有效？一项荟萃分析。
Allergol Immunopathol (Madr). 2015 May-Jun;43(3):298-303. doi: 10.1016/j.aller.2013.09.003. Epub 2013 Nov 11.
10
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.帕利珠单抗用于预防囊性纤维化患儿的呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2010 Feb 17(2):CD007743. doi: 10.1002/14651858.CD007743.pub2.

引用本文的文献

1
The clinical features and impact of SARS-CoV-2/COVID-19 infection in children with Cystic Fibrosis (CF): A Qatari experience.严重急性呼吸综合征冠状病毒2型/冠状病毒病19（SARS-CoV-2/COVID-19）感染对囊性纤维化（CF）儿童的临床特征及影响：卡塔尔的经验
Qatar Med J. 2023 Dec 12;2023(3):19. doi: 10.5339/qmj.2023.19. eCollection 2023.
2
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis.巴西新冠疫情期间因严重急性呼吸道感染住院的囊性纤维化患者的流行病学概况及全球囊性纤维化患者新冠感染情况的系统评价
Healthcare (Basel). 2023 Jul 4;11(13):1936. doi: 10.3390/healthcare11131936.

本文引用的文献

1
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis.关注 COVID-19 中的肺部疾病之外：囊性纤维化患者带来的启示。
Med Hypotheses. 2021 Feb;147:110481. doi: 10.1016/j.mehy.2020.110481. Epub 2021 Jan 4.
2
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study.儿童囊性纤维化患者感染 SARS-CoV-2 的临床特征：一项国际观察性研究。
J Cyst Fibros. 2021 Jan;20(1):25-30. doi: 10.1016/j.jcf.2020.11.021. Epub 2020 Dec 3.
3
Does cystic fibrosis constitute an advantage in COVID-19 infection?囊性纤维化是否构成 COVID-19 感染的优势？
Ital J Pediatr. 2020 Oct 6;46(1):143. doi: 10.1186/s13052-020-00909-1.
4
Impact of COVID-19 on people with cystic fibrosis.新冠病毒病对囊性纤维化患者的影响。
Lancet Respir Med. 2020 May;8(5):e35-e36. doi: 10.1016/S2213-2600(20)30177-6. Epub 2020 Apr 15.